Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E24.40 EPS (ttm)5.61 Insider Own0.10% Shs Outstand2.67B Perf Week-0.50%
Market Cap365.72B Forward P/E15.08 EPS next Y9.08 Insider Trans-16.04% Shs Float2.66B Perf Month1.10%
Income15.30B PEG3.52 EPS next Q2.13 Inst Own69.40% Short Float0.39% Perf Quarter7.29%
Sales81.58B P/S4.48 EPS this Y7.60% Inst Trans0.50% Short Ratio1.44 Perf Half Y-2.53%
Book/sh22.31 P/B6.14 EPS next Y5.76% ROA9.90% Target Price144.71 Perf Year4.36%
Cash/sh7.37 P/C18.58 EPS next 5Y6.93% ROE24.40% 52W Range118.62 - 148.99 Perf YTD6.09%
Dividend3.60 P/FCF40.47 EPS past 5Y3.10% ROI17.00% 52W High-8.11% Beta0.67
Dividend %2.63% Quick Ratio1.20 Sales past 5Y2.70% Gross Margin66.90% 52W Low15.42% ATR1.55
Employees135100 Current Ratio1.50 Sales Q/Q1.00% Oper. Margin22.10% RSI (14)51.95 Volatility1.11% 1.07%
OptionableYes Debt/Eq0.51 EPS Q/Q31.00% Profit Margin18.80% Rel Volume0.89 Prev Close138.10
ShortableYes LT Debt/Eq0.46 EarningsApr 23 BMO Payout62.10% Avg Volume7.29M Price136.91
Recom2.30 SMA20-0.65% SMA502.12% SMA2002.07% Volume6,523,744 Change-0.86%
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
Mar-22-19 01:59PM  11 Dividend Stocks With 55 or More Years of Payout Growth Kiplinger
01:03AM  Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook Moody's
Mar-21-19 06:31PM  J&J to record $700 million charge related to abandoned drug program Reuters
06:21PM  J&J to record $700 million charge related to abandoned drug program Reuters
06:18PM  J&J to record $700 mln charge related to abandoned drug program Reuters
06:09PM  Cramer: Investors need a new playbook now that the Fed ended rate hikes this year CNBC
03:45PM  Heres What the Apple Watch Means for AAPL Stock InvestorPlace
10:19AM  Cooper Companies' (COO) CooperVision Gains Momentum Globally Zacks
09:54AM  Alkermes Focuses on Pipeline, Depends on Partners for Funds Zacks
08:16AM  Dear Apple, Is My Heart OK? Motley Fool
07:51AM  Microsoft Stock Is Just Too Good to Buy Right Now InvestorPlace
Mar-20-19 04:53PM  FedEx, Johnson and Johnson slump while General Mills rises Associated Press
04:19PM  Bayer Stock Tumbles After Jury Finds Weed-Killer Roundup Caused Cancer Investor's Business Daily
11:38AM  US STOCKS-FedEx outlook weighs on Wall St ahead of Fed policy decision Reuters
11:10AM  AbbVie's Venclexta Multiple Myeloma Studies Put on Hold by FDA Zacks
10:17AM  US STOCKS-Wall St drops after weak FedEx outlook; Fed on tap Reuters
08:07AM  Stocks making the biggest moves premarket: General Mills, Johnson & Johnson, Viacom, Sony & more CNBC
Mar-19-19 09:30PM  3 Dividend Stocks Ideal for Retirees Motley Fool
10:53AM  Johnson & Johnson to Host Investor Conference Call on First-Quarter Results PR Newswire
Mar-18-19 05:45PM  Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know Zacks
12:11PM  3 Consumer Staples Stocks to Trade in 2019 InvestorPlace
11:39AM  Are Hedge Funds Right About Berkshire Hathaway Inc. (BRK-B)? Insider Monkey
11:17AM  UnitedHealth Shares Finding Their Mojo Again Investing.com
09:01AM  The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J Zacks
06:00AM  Intuitive Surgical Faces New Competition and FDA Concerns Barrons.com
Mar-15-19 05:33PM  5 Recession-Proof Stocks Motley Fool
12:09PM  The Rally in Johnson & Johnson Looks Like it has Run Its Course TheStreet.com
10:31AM  Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others Zacks
09:39AM  Company News For Mar 15, 2019 Zacks
05:05AM  J&J Seeks Approval for Darzalex in Expanded Patient Group Zacks
Mar-14-19 11:04PM  Jabil Circuit Inc (JBL) Q2 2019 Earnings Conference Call Transcript Motley Fool
09:29PM  The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19) TheStreet.com
07:01PM  Jim Cramer: 5 Examples Show Why Stock Investing Is So Difficult TheStreet.com
06:20PM  Cramer: Five 'perils' of investing in individual stocks CNBC
04:08PM  3 More Outstanding Funds for Dividend Investors Barrons.com
03:46PM  US STOCKS-Wall St near flat as trade deal outlook uncertain Reuters
03:25PM  $18M Johnson & Johnson facility adds strength to Lake Nona's profile American City Business Journals
03:00PM  3 Penny Stocks That Could Make You Rich -- or Regretful Motley Fool
01:16PM  Why Elite, Dividend-Paying Businesses Are the Ultimate Wealth Defense InvestorPlace
01:08PM  US STOCKS-Wall Street muted on trade uncertainty, housing data disappoints Reuters
12:27PM  Johnson & Johnson shares slip after California jury orders it to pay $29 million in latest talcum cancer trial CNBC
12:13PM  J&J Takes Another Hit in Fight Against Asbestos Claims Barrons.com
11:28AM  US STOCKS-Wall St dips on trade uncertainty, weak new home sales data Reuters
10:28AM  US STOCKS-Wall St dips on trade uncertainty, weak new home sales data Reuters
09:39AM  Stocks Trade Flat As Apple, GE Jump: These 3 IPOs Soar Investor's Business Daily
08:48AM  US STOCKS-Wall Street set for muted open as trade uncertainty overhangs Reuters
07:54AM  Stocks making the biggest moves premarket: Boeing, Tesla, General Electric, Facebook & more CNBC
06:58AM  J&J's stock falls after reports company ordered to pay $29 million to woman dying of cancer MarketWatch
04:17AM  Stocks - Boeing, Facebook Fall in Premarket; Apple Rises Investing.com
12:04AM  California jury awards $29 million to woman with cancer who used J&J talc Reuters
Mar-13-19 10:23PM  Johnson & Johnson Hit With $29 Million Verdict in California Talc Suit TheStreet.com
08:41PM  California jury orders J&J to pay $29 million in latest talc cancer trial Reuters
02:27PM  Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study Zacks
07:27AM  The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie Benzinga
Mar-12-19 02:07PM  9 Great Dividend Growth Stocks to Buy Kiplinger
12:53PM  Minerva Neurosciences Inc (NERV) Q4 2018 Earnings Conference Call Transcript Motley Fool
10:09AM  Britain's Smith & Nephew to buy Osiris in regenerative products push Reuters
09:35AM  Home Depot and Johnson & Johnson Are Among Stocks Driving the S&P 500 TheStreet.com
Mar-11-19 05:45PM  Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
12:26PM  Bayer Submits Application in EU for Prostate Cancer Drug Zacks
12:24PM  Johnson & Johnson Buys Large Stake in MeiraGTx Barrons.com
10:06AM  The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's Zacks
02:25AM  Here's Why Arrowhead Pharmaceuticals Gained 38.2% in February Motley Fool
Mar-10-19 07:01PM  Jim Cramer: The Real Lesson of the 10-Year Bull Market Anniversary TheStreet.com
10:36AM  10 Stocks For The Gene Therapy Revolution Investopedia
09:15AM  Better Buy: Abbott Laboratories vs. Johnson & Johnson Motley Fool
Mar-08-19 06:49PM  Can Smart Beta & Factor ETFs Beat the Market? Zacks
01:45PM  Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs Zacks
10:48AM  Major consumer companies make few gains in female representation in board rooms CNBC Videos
10:10AM  Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up Zacks
10:00AM  How to Invest in Woman-Led Companies With ETFs & Stocks Zacks
Mar-07-19 07:22PM  Cramer: A potential 'blockbuster win' for owners of Johnson & Johnson CNBC Videos
07:01PM  Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving TheStreet.com
04:53PM  Why News From J&J, Allergan Could Be A Boon For This Biotech Stock Investor's Business Daily
01:50PM  Monthly shots control HIV as well as pills in 2 big studies Associated Press
10:58AM  Take Profits Now and Buy Shopify Stock on Its Next Big Dip InvestorPlace
10:54AM  Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline Benzinga
10:20AM  Allergan Rises After FDA Accepts License Applications for Botox Supplements TheStreet.com
08:48AM  Allergan's Depression Candidate Fails in Studies, Stock Down Zacks
06:03AM  2 Biotech Stocks With Major Incoming Catalysts Motley Fool
Mar-06-19 03:46PM  Can Smart Beta & Factor ETFs Beat the Market? Zacks
01:14PM  Dow Falls as Investors Eye Details From Trade Talks, Oil Prices Tumble TheStreet.com
01:00PM  J&J prices ketamine-like depression treatment at $590-$885 for two doses Reuters
12:52PM  Jim Cramer on Why Johnson & Johnson's Anti-Depressant Is Important TheStreet.com
12:37PM  Ketamine-Like Depression Drug Isnt a Surefire Hit Bloomberg
12:35PM  U.S. FDA finds asbestos in three Claire's cosmetics products Reuters
12:14PM  The Late Morning Rundown: March 06, 2019 CNBC Videos
11:56AM  Johnson & Johnson Edges Higher After FDA Approves Nasal Spray Antidepressant TheStreet.com
11:23AM  Can Gilead Sciences Return to Winning Ways? GuruFocus.com
10:58AM  Jim Cramer Keeping an Eye on Dollar Tree, GE and Johnson & Johnson TheStreet.com
09:57AM  Jim Cramer: What to Watch from GE, Johnson & Johnson and Dollar Tree TheStreet.com
09:43AM  Stocks Fade Ahead Of Fed Data; This Dow Jones Stock Gets FDA Boost Investor's Business Daily
09:25AM  FDA Approves Major Novel Depression Drug For First Time In 3 Decades Benzinga
08:50AM  J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression Zacks
08:08AM  Stocks making the biggest moves premarket: General Electric, BJ's Wholesale, TripAdvisor & more CNBC
07:54AM  Johnson & Johnson, General Electric, NIO, Abercrombie - 5 Things You Must Know TheStreet.com
07:39AM  The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split Benzinga
07:00AM  Market Morning: FDA Head Resigns, India Strikes Out, Special K Approved, Trade Deficit Explodes Market Exclusive
03:15AM  Stocks - GE Slides in Premarket, Abercrombie and Fitch, Dollar Tree Soar Investing.com
03:07AM  FDA allows treatment of depression with club drug's cousin Associated Press
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM